QuantLogix ← IREN scorecard
📅 IREN Earnings Preview
IREN Limited Ordinary Shares
Next report (est.)
11/09/2026
Countdown
12 days
EPS growth YoY
+0.0%
Revenue growth YoY
-5.2%
Options-implied earnings move
±9.4%
The at-the-money straddle prices a move to roughly $28.10 or $23.28 from $25.69 by 10/30/2026.
Implied vs actual — last 5 reports
ReportOptions impliedActual moveMarket was
08/27/2026 ±7.7% +2.4% over-priced
05/08/2026 ±10.1% +7.7% over-priced
02/05/2026 ±15.7% -11.5% over-priced
11/06/2025 ±11.3% -12.4% under-priced
05/08/2026 ±10.1% +7.7% over-priced
Across these reports, options implied an average ±11.0% move vs an actual average of 8.3% — the stock stayed inside the implied band 80% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q4 FY2026 — $137M $-684M
Q3 FY2026 $-0.74 $145M $-248M
Q2 FY2026 $-0.52 $185M $-155M
Q1 FY2026 $1.08 $240M $385M
Analyst posture
Buy / Strong Buy
21
Hold
4
Sell
0
Strong upward revisions — 28 net (vs 24 prior)
Live 5-factor engine read: Underweight · 23/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on IREN before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

IREN Limited Ordinary Shares (IREN) reports in 12 days, with the next report estimated for 11/09/2026. Across the last 5 reports, options priced an average ±11.0% earnings move while the stock actually moved 8.3% on average — the market has systematically over-priced IREN's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue down 5.2%. QuantLogix's live 5-factor engine currently reads IREN as a underweight at 23/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →